Pre-Emption Rights

Pre-emption rights are rights given to a company's existing shareholders to subscribe for newly issued shares, in proportion to the shares they already hold, before those shares can be offered to outsiders. They protect shareholders against dilution: without them, a company could issue shares to new investors, reducing each existing holder's percentage of votes and dividends, and, if the shares were sold below market value, transferring wealth from old holders to new ones.

The term is used in the United Kingdom, Ireland, continental Europe and Commonwealth countries; in the United States the equivalent is the preemptive right. The phrase also describes a different arrangement, common in private companies and joint ventures, under which a shareholder wishing to sell must first offer the shares to the other shareholders. This entry concerns rights on a new issue of shares.

In the United Kingdom, the Companies Act 2006 provides that a company proposing to allot equity securities for cash must first offer them to existing ordinary shareholders pro rata, on the same or more favourable terms, and allow a minimum period for acceptance. The right is statutory and applies to public and private companies alike, although private companies may exclude it in their articles. It does not apply to shares issued for non-cash consideration, such as shares issued to acquire another business, or to shares issued under employee share schemes.

European Union company law imposes a similar requirement on public companies in every member state, derived from a directive first adopted in the 1970s. In the United States the position is the reverse. Under the corporate statutes of Delaware and most other states, shareholders have no preemptive rights unless the certificate of incorporation grants them, and listed companies rarely do so. Protection against dilution there comes instead from stock exchange rules requiring a shareholder vote on large discounted issues and from directors' fiduciary duties.

A company honours pre-emption rights by structuring its fundraising as an offer to existing holders. The principal forms are:

• Rights issue. Shareholders receive tradable rights to buy new shares at a discount. A holder who does not wish to subscribe can sell the rights and so receive compensation for the dilution. See subscription rights and rights issue processing.
• Open offer. Shareholders are invited to subscribe pro rata, but the entitlement cannot be sold, so those who do not take it up are diluted without compensation. See open offer processing.
• Placing with clawback. New shares are placed conditionally with institutions, subject to the right of existing holders to claim their proportion.

These methods take longer and cost more than selling shares directly to a small group of investors, because they require a prospectus or offer document, an offer period and often underwriting.

Because pre-emptive offers are slow, the law allows shareholders to waive the right in advance. In the United Kingdom this requires a special resolution, passed by at least 75 per cent of votes cast, and listed companies routinely seek a limited disapplication at each annual shareholder meeting.

How much dilution investors will accept is governed by guidance rather than statute. The Pre-Emption Group, a body representing listed companies, investors and intermediaries, publishes a statement of principles. Following a government-commissioned review of secondary capital raising, the principles were revised in November 2022 to support a general disapplication of up to 10 per cent of issued share capital for any purpose, plus a further 10 per cent for an acquisition or specified capital investment, in each case with a small additional amount for follow-on offers to retail shareholders. The previous limits were 5 per cent plus 5 per cent. Companies using the authority are expected to consult major shareholders, explain the background, give retail investors a chance to take part where possible, and report afterwards. Non-pre-emptive placings are usually carried out by accelerated book building at a limited discount.

For institutional shareholders, pre-emption is a core governance protection. It prevents management from placing shares with friendly investors to entrench itself, and it ensures that if shares are sold cheaply the benefit goes to existing owners. Institutions have historically defended it strongly in the United Kingdom, and voting guidelines from investor bodies advise opposing resolutions that exceed the accepted limits.

For companies, the cost is flexibility. A company that needs funds quickly, for an acquisition or in a crisis, may not be able to wait several weeks for a rights issue. During the pandemic in 2020, the Pre-Emption Group temporarily supported placings of up to 20 per cent so that companies could raise emergency capital, and the experience informed the later permanent relaxation. Critics of strict pre-emption argue that it raises the cost of capital and has made public markets less attractive than private funding; supporters reply that predictable protection lowers the return investors demand.

Pre-emption sits alongside other shareholder safeguards on changes to share capital, including approval requirements for a share buyback and limits on issuing shares from authorised share capital. In venture capital and private equity, contractual pre-emption on new issues, often called a pro rata right, lets investors maintain their stake in later funding rounds, and is negotiated together with anti-dilution adjustments. A new issue changes the company's issued share capital and requires an update to the share register.